A 3-ARM, PHASE IIA TRIAL OF SAFETY & EFFICACY OF OLINVACIMAB, A MONOCLONAL ANTIBODY TO VEGFR2 IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME WITH IMAGING AND PK/PD ASSESSMENTS: FINAL REPORT Conference Paper uri icon

authors

  • Cher, Lawrence
  • Nowak, Anna
  • Iatropoulos, George
  • Bowyer, Samantha
  • Gan, Hui
  • Long, Anne Poh
  • Bynevelt, Michael
  • Jackson, Graeme
  • Lee, Seon Young
  • Lee, Weon Sup
  • Yoo, Jin-San

publication date

  • November 1, 2020